Pioneering reproductive therapies.


Pregena develops advanced cell therapy protocols for reproductive medicine, with a focus on hCG-primed PBMC therapy to improve IVF outcomes. We are bridging the gap between immunology research and clinical application to give patients better chances at building their families.

Research

Advancing the science of reproductive immunology through rigorous investigation and clinical collaboration.

Therapy

Developing next-generation cell therapy protocols that translate breakthrough research into patient-ready treatments.

Outcomes

Improving success rates for patients worldwide through evidence-based, innovative therapeutic approaches.